HDL Dysfunction During the Acute Stage of Stroke "RUSH"


Phase N/A Results N/A

Summary of Purpose

The study investigates the effect of plasma myeloperoxidase (MPO) concentrations on HDL dysfunction during the acute stage of ischemic and haemorrhagic strokes.

Read More →

Trial Milestones

The following dates are available for this trial. Trial information last updated on 18 December 2017.

20 Oct 2017 8 Aug 2017 1 Oct 2018 1 Mar 2019 1 Dec 2017 Unavailable
Start Date First Received 1st Completion Completion Verification Results

Trial Design

Not available